PCM

Perkins Capital Management Portfolio holdings

AUM $133M Turnover 16.67%
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$94.7M
AUM Growth
+$5.36M
Cap. Flow
+$2.1M
Cap. Flow %
2.21%
Top 10 Hldgs %
35.56%
Holding
109
New
5
Increased
19
Reduced
37
Closed
9
Avg Time Held
4 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
2 years

Top Buys

Rank Stock Value
1
AUGX icon
Augmedix, Inc. Common Stock
AUGX
+$1.57M
2
SKYT icon
SkyWater Technology
SKYT
+$1.18M
3
EGHT icon
8x8 Inc
EGHT
+$838K
4
USIO icon
Usio Inc
USIO
+$566K
5
ELUT icon
Elutia
ELUT
+$255K

Top Sells

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$969K
2
UPH
UpHealth, Inc.
UPH
+$415K
3
CSII
Cardiovascular Systems, Inc.
CSII
+$335K
4
RNG icon
RingCentral
RNG
+$221K
5
QUMU
Qumu Corp.
QUMU
+$148K

Sector Composition

Rank Sector Weight
1 Healthcare 57.13%
2 Technology 22.19%
3 Communication Services 7.13%
4 Industrials 6.74%
5 Consumer Staples 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LLY icon
1
Eli Lilly
LLY
$1.08T
$4.83M 5.1%
13,216
– –
2013 Q2
38 quarters
IDXX icon
2
Idexx Laboratories
IDXX
$41.5B
$4.41M 4.65%
10,805
– –
2013 Q3
37 quarters
DGII icon
3
Digi International
DGII
$2.73B
$3.98M 4.2%
108,883
-1,550
-1% -$59.7K
2020 Q1
11 quarters
MSFT icon
4
Microsoft
MSFT
$3.97T
$3.67M 3.88%
15,326
– –
2014 Q1
35 quarters
AXGN icon
5
Axogen
AXGN
$2.08B
$3.06M 3.23%
307,040
+400
+0.1% +$4.44K
2013 Q3
37 quarters
VCYT icon
6
Veracyte
VCYT
$3.48B
$2.92M 3.08%
123,030
-500
-0.4% -$11.6K
2018 Q1
19 quarters
ABT icon
7
Abbott
ABT
$178B
$2.91M 3.07%
26,480
-500
-2% -$51.8K
2014 Q1
35 quarters
PERI icon
8
Perion Network
PERI
$347M
$2.7M 2.85%
106,571
-150
-0.1% -$3.65K
2021 Q1
7 quarters
AUGX icon
9
DELISTED
Augmedix, Inc. Common Stock
AUGX
$2.62M 2.77%
1,680,428
+1,233,528
+276% +$1.57M
2021 Q4
4 quarters
PFE icon
10
Pfizer
PFE
$167B
$2.58M 2.73%
50,416
-800
-2% -$38.4K
2013 Q2
38 quarters
NTRA icon
11
Natera
NTRA
$57.4B
$2.49M 2.63%
61,900
-150
-0.2% -$6.18K
2018 Q2
18 quarters
STRM icon
12
DELISTED
Streamline Health Solutions
STRM
$2.47M 2.6%
104,095
-4,014
-4% -$97.7K
2018 Q2
18 quarters
ATEC icon
13
Alphatec Holdings
ATEC
$1.61B
$2.26M 2.38%
182,717
-1,000
-0.5% -$10.1K
2019 Q3
13 quarters
TELA icon
14
TELA Bio
TELA
$47.4M
$1.99M 2.1%
173,250
-500
-0.3% -$4.48K
2022 Q3
1 quarter
OOMA icon
15
Ooma
OOMA
$548M
$1.98M 2.09%
145,400
-650
-0.4% -$9.62K
2018 Q2
18 quarters
ABBV icon
16
AbbVie
ABBV
$501B
$1.88M 1.98%
11,608
– –
2019 Q1
15 quarters
NEO icon
17
NeoGenomics
NEO
$2.17B
$1.83M 1.93%
197,700
+2,150
+1% +$20K
2013 Q2
38 quarters
LMAT icon
18
LeMaitre Vascular
LMAT
$1.89B
$1.73M 1.83%
37,586
-1,314
-3% -$61.5K
2022 Q3
1 quarter
OPRX icon
19
OptimizeRx
OPRX
$156M
$1.71M 1.81%
101,763
+200
+0.2% +$3.46K
2018 Q2
18 quarters
GIS icon
20
General Mills
GIS
$17.1B
$1.7M 1.8%
20,325
– –
2017 Q4
20 quarters
AMD icon
21
Advanced Micro Devices
AMD
$932B
$1.66M 1.76%
25,684
– –
2018 Q1
19 quarters
PFIE icon
22
DELISTED
Profire Energy, Inc
PFIE
$1.52M 1.6%
1,429,830
-23,685
-2% -$24.1K
2016 Q2
26 quarters
ATRC icon
23
AtriCure
ATRC
$2.93B
$1.48M 1.56%
33,350
-1,000
-3% -$41.8K
2013 Q2
38 quarters
MGNI icon
24
Magnite
MGNI
$3.43B
$1.44M 1.52%
136,075
– –
2018 Q2
18 quarters
MRK icon
25
Merck
MRK
$364B
$1.32M 1.4%
11,925
– –
2016 Q4
24 quarters
1
2 3 4 5

Similar funds

AA
Alpha Advisors Richmond, Virginia $133M AUM 20.23% 1-Year Est. Return
WA
Winter & Associates St. Paul, Minnesota $133M AUM
AC
Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $133M AUM 50.19% 1-Year Est. Return
HAP
Harbor Asset Planning Belmont, Massachusetts $133M AUM 24.86% 1-Year Est. Return
RHIG
R.H. Investment Group Scottsdale, Arizona $133M AUM 23.61% 1-Year Est. Return
CWM
Capstone Wealth Management Billings, Montana $133M AUM
SI
Severin Investments St. Louis, Missouri $133M AUM 45.69% 1-Year Est. Return

Perkins Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Perkins Capital Management held 109 positions worth $94.7M, up 6% from $89.4M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Perkins Capital Management's Q4 2022 filing shows 5 new, 19 increased, 37 reduced and 9 closed positions. Its largest new stake was SkyWater Technology: 140,000 shares worth $995K. The largest sale was CareDx, an estimated $969K.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 58% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q4 2022 buy was SkyWater Technology: 140,000 shares worth $995K.
  • Perkins Capital Management added most to Augmedix, Inc. Common Stock in Q4 2022, an estimated $1.57M increase.
  • Perkins Capital Management's biggest Q4 2022 reduction was Biolase, Inc., cutting an estimated $124K.
  • Perkins Capital Management fully exited CareDx in Q4 2022, selling an estimated $969K.
  • Perkins Capital Management's ten largest holdings make up 36% of its $94.7M portfolio in Q4 2022.
  • Perkins Capital Management opened 5 new positions and closed 9 in Q4 2022.
  • Perkins Capital Management's portfolio value rose 6% quarter-over-quarter to $94.7M.

Based on Perkins Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.